These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34612174)

  • 1. L-asparaginase from
    Saeed H; Elsawy E; Shalaby M; Abdel-Fattah M; Hemida A; Eldoksh A; Ataya FS; Nematalla H; Elkewedi M; Labrou NN; El-Nikhely N
    Prep Biochem Biotechnol; 2022; 52(6):668-680. PubMed ID: 34612174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
    Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
    Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-asparaginase production review: bioprocess design and biochemical characteristics.
    Castro D; Marques ASC; Almeida MR; de Paiva GB; Bento HBS; Pedrolli DB; Freire MG; Tavares APM; Santos-Ebinuma VC
    Appl Microbiol Biotechnol; 2021 Jun; 105(11):4515-4534. PubMed ID: 34059941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product.
    Schnuchel A; Radcke C; Theobald L; Doeding S
    PLoS One; 2023; 18(6):e0285948. PubMed ID: 37319282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.
    Saeed H; Hemida A; El-Nikhely N; Abdel-Fattah M; Shalaby M; Hussein A; Eldoksh A; Ataya F; Aly N; Labrou N; Nematalla H
    Int J Biol Macromol; 2020 Aug; 156():812-828. PubMed ID: 32311402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.
    Chien WW; Allas S; Rachinel N; Sahakian P; Julien M; Le Beux C; Lacroix CE; Abribat T; Salles G
    Invest New Drugs; 2014 Oct; 32(5):795-805. PubMed ID: 24829072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus sonorensis L. Asparaginase: Cloning, Expression in E. coli and Characterization.
    Aly N; El-Ahwany A; Ataya FS; Saeed H
    Protein J; 2020 Dec; 39(6):717-729. PubMed ID: 33106988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
    Kotzia GA; Labrou NE
    J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.
    Salzer WL; Asselin BL; Plourde PV; Corn T; Hunger SP
    Ann N Y Acad Sci; 2014 Nov; 1329():81-92. PubMed ID: 25098829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
    Yamada T; Ishimaru M; Shoji T; Tomiyasu H; Tochinai R; Taguchi K; Komatsu T
    ACS Appl Bio Mater; 2023 Dec; 6(12):5789-5797. PubMed ID: 38047730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial L-asparaginase as a promising enzyme for treatment of various cancers.
    Darvishi F; Jahanafrooz Z; Mokhtarzadeh A
    Appl Microbiol Biotechnol; 2022 Sep; 106(17):5335-5347. PubMed ID: 35871694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-aspartylpeptides as substrates of L-asparaginases from Escherichia coli and Erwinia chrysanthemi.
    Kelo E; Noronkoski T; Stoineva IB; Petkov DD; Mononen I
    FEBS Lett; 2002 Sep; 528(1-3):130-2. PubMed ID: 12297292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.
    Miranda J; Lefin N; Beltran JF; Belén LH; Tsipa A; Farias JG; Zamorano M
    BioDrugs; 2023 Nov; 37(6):793-811. PubMed ID: 37698749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Design of a Chimeric Humanized L-asparaginase.
    Pedroso A; Herrera Belén L; Beltrán JF; Castillo RL; Pessoa A; Pedroso E; Farías JG
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, purification, and characterization of asparaginase II from Saccharomyces cerevisiae in Escherichia coli.
    Lopes W; Santos BAFD; Sampaio ALF; Gregório Alves Fontão AP; Nascimento HJ; Jurgilas PB; Torres FAG; Bon EPDS; Almeida RV; Ferrara MA
    Protein Expr Purif; 2019 Jul; 159():21-26. PubMed ID: 30836141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase
    Gao C; Ma X; Zhang Z; Lu Q; Ashby CR; Wei L; Chen ZS
    Drugs Today (Barc); 2022 Jun; 58(6):261-271. PubMed ID: 35670704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-Asparaginase.
    Modi T; Gervais D
    Invest New Drugs; 2022 Feb; 40(1):21-29. PubMed ID: 34468906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of glutaminase-free L-asparaginases from Himalayan Pseudomonas and Rahnella spp. for acrylamide mitigation.
    Patial V; Kumar S; Joshi R; Singh D
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128576. PubMed ID: 38048933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum.
    Lanvers C; Vieira Pinheiro JP; Hempel G; Wuerthwein G; Boos J
    Anal Biochem; 2002 Oct; 309(1):117-26. PubMed ID: 12381370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can recombinant technology address asparaginase Erwinia chrysanthemi shortages?
    Maese L; Rizzari C; Coleman R; Power A; van der Sluis I; Rau RE
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29169. PubMed ID: 34105243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.